Abstract
Human immunodeficiency virus (HIV) evolves within infected persons to escape being destroyed by the host immune system, thereby preventing effective immune control of infection. Here, we combine methods from evolutionary dynamics and statistical physics to simulate in vivo HIV sequence evolution, predicting the relative rate of escape and the location of escape mutations in response to T-cell-mediated immune pressure in a cohort of 17 persons with acute HIV infection. Predicted and clinically observed times to escape immune responses agree well, and we show that the mutational pathways to escape depend on the viral sequence background due to epistatic interactions. The ability to predict escape pathways and the duration over which control is maintained by specific immune responses open the door to rational design of immunotherapeutic strategies that might enable long-term control of HIV infection. Our approach enables intra-host evolution of a human pathogen to be predicted in a probabilistic framework.
Original language | English |
---|---|
Article number | 11660 |
Journal | Nature Communications |
Volume | 7 |
DOIs | |
State | Published - 23 May 2016 |
Externally published | Yes |
Bibliographical note
Funding Information:This research was funded by the Ragon Institute of MGH, MIT and Harvard (J.P.B., A.K.C. and B.D.W.), National Institute of Allergy and Infectious Diseases, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1-AI100663 (to B.D.W.), a Creative and Novel Ideas in HIV Research award P30 AI9227763 (to N.G.) and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1-AI100645-01 (to A.J.M.).
Funding
This research was funded by the Ragon Institute of MGH, MIT and Harvard (J.P.B., A.K.C. and B.D.W.), National Institute of Allergy and Infectious Diseases, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1-AI100663 (to B.D.W.), a Creative and Novel Ideas in HIV Research award P30 AI9227763 (to N.G.) and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1-AI100645-01 (to A.J.M.).
Funders | Funder number |
---|---|
Ragon Institute of MGH | |
National Institute of Allergy and Infectious Diseases | P30 AI9227763, UM1-AI100663, UM1AI100645 |
Massachusetts Institute of Technology | |
Harvard University | |
Medical Research Council | MR/K012037/1 |